ArticleCureus2025
Communicating Hydrocephalus After Radiotherapy for a Vestibular Schwannoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrocephalus is a known tumour complication associated with vestibular schwannomas, which can be either the obstructive or communicating (non-obstructive) type. The latter represents a rare and controversial complication following radiotherapy, typically resulting from tumour necrosis. Management generally involves cerebrospinal fluid diversion. Here, we present a case of normal-pressure and communicating hydrocephalus that developed after radiotherapy for a vestibular schwannoma. The patient was a 72-year-old woman who initially presented with imbalance and right sensorineural hearing loss. An MRI scan identified an enhancing mass in the right cerebellopontine angle and the right internal auditory meatus, consistent with a diagnosis of a right vestibular schwannoma. Following evidence of increased tumour growth on subsequent MRI scans, the patient underwent radiotherapy with a total dose of 50 Gy delivered in 30 fractions, utilising the volumetric modulated arc therapy technique. Sixteen months after radiotherapy, the patient experienced new neurological symptoms, including intermittent slurred speech, loss of concentration, slow cognition, right facial asymmetry, numbness, and recurrent falls. CT of the head showed communicating hydrocephalus. Therefore, a left ventriculoperitoneal shunt was subsequently inserted for the management of hydrocephalus. However, due to shunt blockage, the patient underwent near-total resection of the enlarging vestibular schwannoma and has since been followed by the neurosurgical team.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.